Gene Review:
qacJ - qacJ
Staphylococcus aureus
Kaatz,
Thyagarajan,
Seo,
Pereda-Miranda,
Kaatz,
Gibbons,
Mereghetti,
Quentin,
Marquet-Van Der Mee,
Audurier,
Bayer,
Kupferwasser,
Brown,
Skurray,
Grkovic,
Jones,
Mukhopadhay,
Yeaman,
Kaatz,
Moudgal,
Seo,
Hansen,
Kristiansen,
Bjorland,
Steinum,
Sunde,
Waage,
Heir,
Kaatz,
Moudgal,
Seo,
Kaatz,
Demarco,
Seo,
Lin,
Connelly,
Amolo,
Otani,
Yaver,
Bonomo,
Rice,
Gibbons,
Moser,
Kaatz,
Tanaka,
Wang,
Onodera,
Uchida,
Sato,
Kaatz,
Seo,
O'Brien,
Wahiduzzaman,
Foster,
- Novel plasmid-borne gene qacJ mediates resistance to quaternary ammonium compounds in equine Staphylococcus aureus, Staphylococcus simulans, and Staphylococcus intermedius. Bjorland, J., Steinum, T., Sunde, M., Waage, S., Heir, E. Antimicrob. Agents Chemother. (2003)
- The multidrug efflux transporter of Bacillus subtilis is a structural and functional homolog of the Staphylococcus NorA protein. Neyfakh, A.A. Antimicrob. Agents Chemother. (1992)
- Emerging issues in antibiotic resistant infections in long-term care facilities. Bonomo, R.A., Rice, L.B. J. Gerontol. A Biol. Sci. Med. Sci. (1999)
- Localization of the forskolin labeling sites to both halves of P-glycoprotein: similarity of the sites labeled by forskolin and prazosin. Morris, D.I., Greenberger, L.M., Bruggemann, E.P., Cardarelli, C., Gottesman, M.M., Pastan, I., Seamon, K.B. Mol. Pharmacol. (1994)
- Low-level resistance of Staphylococcus aureus to thrombin-induced platelet microbicidal protein 1 in vitro associated with qacA gene carriage is independent of multidrug efflux pump activity. Bayer, A.S., Kupferwasser, L.I., Brown, M.H., Skurray, R.A., Grkovic, S., Jones, T., Mukhopadhay, K., Yeaman, M.R. Antimicrob. Agents Chemother. (2006)
- MepR, a Repressor of the Staphylococcus aureus MATE Family Multidrug Efflux Pump MepA, Is a Substrate-Responsive Regulatory Protein. Kaatz, G.W., Demarco, C.E., Seo, S.M. Antimicrob. Agents Chemother. (2006)
- Global transcriptional response of Bacillus subtilis to treatment with subinhibitory concentrations of antibiotics that inhibit protein synthesis. Lin, J.T., Connelly, M.B., Amolo, C., Otani, S., Yaver, D.S. Antimicrob. Agents Chemother. (2005)
- Effect of promoter region mutations and mgrA overexpression on transcription of norA, which encodes a Staphylococcus aureus multidrug efflux transporter. Kaatz, G.W., Thyagarajan, R.V., Seo, S.M. Antimicrob. Agents Chemother. (2005)
- The effect of reserpine, an inhibitor of multidrug efflux pumps, on the in-vitro activities of ciprofloxacin, sparfloxacin and moxifloxacin against clinical isolates of Staphylococcus aureus. Schmitz, F.J., Fluit, A.C., Lückefahr, M., Engler, B., Hofmann, B., Verhoef, J., Heinz, H.P., Hadding, U., Jones, M.E. J. Antimicrob. Chemother. (1998)
- Phenylpiperidine selective serotonin reuptake inhibitors interfere with multidrug efflux pump activity in Staphylococcus aureus. Kaatz, G.W., Moudgal, V.V., Seo, S.M., Hansen, J.B., Kristiansen, J.E. Int. J. Antimicrob. Agents (2003)
- The multidrug efflux pump NorA is not required for salicylate-induced reduction in drug accumulation by Staphylococcus aureus. Price, C.T., Kaatz, G.W., Gustafson, J.E. Int. J. Antimicrob. Agents (2002)
- Structural differences between paroxetine and femoxetine responsible for differential inhibition of Staphylococcus aureus efflux pumps. Wei, P., Kaatz, G.W., Kerns, R.J. Bioorg. Med. Chem. Lett. (2004)
- The effect of reserpine, a modulator of multidrug efflux pumps, on the in vitro activity of tetracycline against clinical isolates of methicillin resistant Staphylococcus aureus (MRSA) possessing the tet(K) determinant. Gibbons, S., Udo, E.E. Phytotherapy research : PTR. (2000)
- Identification and characterization of a novel efflux-related multidrug resistance phenotype in Staphylococcus aureus. Kaatz, G.W., Moudgal, V.V., Seo, S.M. J. Antimicrob. Chemother. (2002)
- Antibacterial and resistance modifying activity of Rosmarinus officinalis. Oluwatuyi, M., Kaatz, G.W., Gibbons, S. Phytochemistry (2004)
- Gene cloning and characterization of SdrM, a chromosomally-encoded multidrug efflux pump, from Staphylococcus aureus. Yamada, Y., Hideka, K., Shiota, S., Kuroda, T., Tsuchiya, T. Biol. Pharm. Bull. (2006)
- Evidence for the existence of a multidrug efflux transporter distinct from NorA in Staphylococcus aureus. Kaatz, G.W., Seo, S.M., O'Brien, L., Wahiduzzaman, M., Foster, T.J. Antimicrob. Agents Chemother. (2000)
- Response of Staphylococcus aureus to Salicylate Challenge. Riordan, J.T., Muthaiyan, A., Van Voorhies, W., Price, C.T., Graham, J.E., Wilkinson, B.J., Gustafson, J.E. J. Bacteriol. (2007)
- Catechin gallates inhibit multidrug resistance (MDR) in Staphylococcus aureus. Gibbons, S., Moser, E., Kaatz, G.W. Planta Med. (2004)
- Topoisomerase mutations and efflux are associated with fluoroquinolone resistance in Enterococcus faecalis. Oyamada, Y., Ito, H., Inoue, M., Yamagishi, J. J. Med. Microbiol. (2006)
- Low sensitivity of Listeria monocytogenes to quaternary ammonium compounds. Mereghetti, L., Quentin, R., Marquet-Van Der Mee, N., Audurier, A. Appl. Environ. Microbiol. (2000)
- Polyacylated oligosaccharides from medicinal Mexican morning glory species as antibacterials and inhibitors of multidrug resistance in Staphylococcus aureus. Pereda-Miranda, R., Kaatz, G.W., Gibbons, S. J. Nat. Prod. (2006)
- Mechanism of quinolone resistance in Staphylococcus aureus. Tanaka, M., Wang, T., Onodera, Y., Uchida, Y., Sato, K. J. Infect. Chemother. (2000)